Início › Câncer Colorretal › Ohio

Ensaios clínicos de Câncer Colorretal em Ohio

63 estudos para Câncer Colorretal estão buscando participantes em locais em Ohio.

Cidades em Ohio

Texto oficial do estudo (Inglês)

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Miami Valley Hospital South, Centerville
Ohio State University Comprehensive Cancer Center, Columbus
Miami Valley Hospital, Dayton
e mais 4

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05673148

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Oncology Hematology Care - Blue Ash /ID# 280143, Cincinnati

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07525206

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

The Cleveland Clinic Taussig Cancer Center, Cleveland

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Summa Health System - Akron Campus, Akron
Cleveland Clinic Akron General, Akron
Summa Health System - Barberton Campus, Barberton
e mais 44

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Family Communications After Genetic Testing

Aultman Alliance Community Hospital, Alliance
Indu and Raj Soin Medical Center, Beavercreek
Saint Elizabeth Boardman Hospital, Boardman
e mais 17

RecrutandoVoluntários saudáveis bem-vindos

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07143487

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Cleveland Clinic - Oncology Department, Cleveland

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06760819

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #10, Cleveland

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT05176483

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ALX Center 10, Columbus

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07085091

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
University of Cincinnati Cancer Center-West Chester, West Chester

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05803382

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

Oncology Hematology Care - Eastgate /ID# 271493, Cincinnati

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06820463

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Oncology Hematology Care - Eastgate, Cincinnati
University Hospitals Cleveland Medical Center, Cleveland
Oncology Hematology Care Clinical Trials, LLC, Fairfield

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07222800

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

The Ohio State University Comprehensive Cancer Center, Columbus

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT04981119

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Gabrail Cancer Center, Canton
University Hospital of Cleveland, Cleveland

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06750094

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Gabrail Cancer Center, Canton
University Hospitals Cleveland Medical Center, Cleveland
Cleveland Clinic Cancer Center Fairview Hospital Moll Pavilion, Cleveland
e mais 8

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06662786

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Ohio State University Comprehensive Cancer Center, Columbus
Saint Elizabeth Youngstown Hospital, Youngstown

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT05863195

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07221357

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, Cincinnati
Research Site, Columbus

RecrutandoFase 2

Idades de 18 a 130 · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT05489211

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

Ohio State University Comprehensive Cancer Center, Columbus

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT06102902

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

University of Cincinnati Medical Center, Cincinnati

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06445062

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Cleveland Clinic, Cleveland

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT05786924

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

GSK Investigational Site, Canton

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07213609

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

University of Cincinnati Cancer Institute, Cincinnati
Case Comprehensive Cancer Center, Cleveland
Ohio State University-Arthur G James Comprehensive Cancer Center, Columbus
e mais 2

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07284849

Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis

Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07044362

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

Cleveland Clinic Foundation, Cleveland
Ohio State University Comprehensive Cancer Center, Columbus

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT05630794

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Clinical Study Site, Akron
Clinical Study Site, Canton
Clinical Study Site, Cincinnati
e mais 4

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT07228832

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

The Ohio State University (OSU) Wexner Medical Center, Columbus

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06400472

The Vanguard Study: Testing a New Way to Screen for Cancer

Louis Stokes Cleveland VA Medical Center, Cleveland

RecrutandoVoluntários saudáveis bem-vindos

Idades de 45 a 75 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06995898

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

University of Cincinnati Cancer Center, Cincinnati

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT07544589

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Cincinnati Children's Hospital Medical Center, Cincinnati

RecrutandoFase 1/2

12 Months – 30 Years · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04851119

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

University of Cincinnati (UC) - Cancer Institute, Cincinnati
Cleveland Clinic, Cleveland

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT06586515

FOG-001 in Locally Advanced or Metastatic Solid Tumors

University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
Cleveland Clinic, Cleveland

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05919264

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

The Ohio State University Comprehensive Cancer Center, Columbus

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT05592626

Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
University of Cincinnati Cancer Center-West Chester, West Chester

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT06654037

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Oncology Hematology Care Primary, Cincinnati
Taylor Cancer Research Center, Maumee

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de jul. de 2026 · NCT04657068

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Cleveland Clinic, Cleveland
Ohio State University, Columbus
Taylor Cancer Research Center, Maumee

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT03526835

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

The Ohio State University Comprehensive Cancer Center, Columbus

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT06948448

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

Zangmeister Cancer Center, Columbus

RecrutandoFase 4

Idades 18 e acima · Todos os sexos · Atualizado em 7 de jul. de 2026 · NCT06562543

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Ohio State University, Columbus

RecrutandoFase 1/2

Idades de 18 a 90 · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT06710756

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de jul. de 2026 · NCT07079631

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

The Ohio State University Comprehensive Cancer Center, Columbus

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 12 de jun. de 2026 · NCT06051695

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.